Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The mTOR inhibitor Everolimus is approved for the treatment of PanNET and no predictive biomarker is available. mTOR is a central node controlling mitochondrial and aerobic glycolytic metabolisms.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Cros J, Bucau M, Raffenne J, Soukeur M, Dumont F,
Keywords: mTOR, everolimus, pancreatic NET, metabolism,
#707 Neuroendocrine Carcinoma: Surgery of Peritoneal Metastasis
Introduction: Neuroendocrine tumor (NET)-derived peritoneal metastases (PM) are not really described nor taken into account in the literature, yet they exert an impact on overall survival (OS)
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Dumont F
Authors: Elias D, David A, Sourouille I, Honoré C, Goéré D,
Keywords: neuroendocrine tumor, peritoneal metastases, hyperthermic intraperitoneal chemotherapy,
Introduction: Well-differenciated locally advanced Pancreatic Neuroendocrine Tumors (PNET) lead to significant local complications due to segmental portal hypertension (SPH).
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Dumont F
Authors: Goudard Y, Dumont F, Caramella C, Goéré D, Honoré C,
Keywords: pancreatic neuroendocrine tumors, segmental portal hypertension, locally advanced,